journal article·2023-06Open access

Celastrol-based nanoporous membranes prevent subconjunctival fibrosis by activating autophagy

Zhanrong Li, Zhihua Guo, Dandan Chu, Ruixing Liu, Lei Zhu, Liuqi Shi, Chengcheng Li, Lin Jin, Xingcai Zhang, Jingguo Li

Abstract

Subconjunctival fibrosis is the final manifestation of various ocular surface injuries and inflammatory diseases; however, clinical treatment is not currently available to prevent or reverse this condition. Celastrol, a triterpene derived from Tripterygium wilfordii, is a potent antifibrotic agent. However, the underlying mechanism of the effect of celastrol on subconjunctival fibrosis remains unknown. It is difficult to choose the method of administration to improve the antifibrotic effect of drugs on subconjunctival fibrosis. In this study, we developed a class of porous nanofibrous membranes loaded with celastrol for sustainable release and hyaluronic acid as a coating layer to prevent burst release. The SEM images indicated that the nanopores and coating layer were clearly observed. In addition, Western blot and confocal microscopic analysis of human pterygium fibroblasts revealed that celastrol induced autophagy. Moreover, celastrol increased the expression of LC3 II in subconjunctival tissue and inhibited the expression of FN and COLⅠ in rats. This finding suggests that autophagy induction by celastrol protects against subconjunctival fibrosis. Furthermore, we revealed that celastrol activated autophagy by inhibiting the PI3K/Akt/mTOR pathway. Moreover, the porous nanofibrous membrane exhibited excellent biocompatibility for potential application in future clinical translation. Thus, this study reveals the importance of autophagy as a possible therapeutic target and celastrol as a potential candidate drug against subconjunctival fibrosis, demonstrating an alternative to inhibit fibrosis, and extend ocular sustainable delivery of various drugs to treat eye diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ocular Diseases and Behçet’s Syndrome · Natural Compounds in Disease Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Nature-derived bionanomaterials for gradient-release of 5-fluorouracil to inhibit subconjunctival fibrosis
2. Autophagic cell death restricts chromosomal instability during replicative crisis10.1038/s41586-019-0885-0 ↗
3. Emerging connectivity of programmed cell death pathways and its physiological implications10.1038/s41580-020-0270-8 ↗
4. Autophagy in kidney homeostasis and disease10.1038/s41581-020-0309-2 ↗
5. Autophagy attenuates tubulointerstital fibrosis through regulating transforming growth factor-β and NLRP3 inflammasome signaling pathway10.1038/s41419-019-1356-0 ↗
6. Trehalose attenuates TGF-β1-induced fibrosis of hSCFs by activating autophagy10.1007/s11010-020-03760-4 ↗
7. Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-κB and Notch1 pathways
8. Reduction-sensitive nanomicelles: delivery celastrol for retinoblastoma cells effective apoptosis10.1016/j.cclet.2020.03.066 ↗
9. Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles10.1080/10717544.2020.1730522 ↗
10. Treatment of obesity with celastrol10.1016/j.cell.2015.05.011 ↗
11. Autophagy induction by celastrol augments protection against bleomycin-induced experimental pulmonary fibrosis in rats: role of adaptor protein p62/SQSTM110.1016/j.pupt.2017.04.003 ↗
12. Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats10.2147/IJN.S117425 ↗
13. Emerging porous organic polymers for biomedical applications10.1039/D1CS00871D ↗
14. Size engineering of 2D MOF nanosheets for enhanced photodynamic antimicrobial therapy
15. Novel silicon oxide anode material builds high-energy lithium-ion batteries
16. Thermo-gelling dendronized chitosans as biomimetic scaffolds for corneal tissue engineering10.1021/acsami.1c16087 ↗
17. Synergistic cobalt sulfide/eggshell membrane carbon electrode10.1021/acsami.9b06934 ↗
18. Molybdenum-based nanomaterials for photothermal cancer therapy10.1002/anbr.202200065 ↗
19. Ca2+-supplying black phosphorus-based scaffolds fabricated with microfluidic technology for osteogenesis
20. Critical role of mTORC2-Akt signaling in TGF-β1-induced myofibroblast differentiation of human pterygium fibroblasts10.1167/iovs.18-25376 ↗
21. Investigation of conjunctival fibrosis response using a 3D glaucoma tenon's capsule + conjunctival model10.1167/iovs.18-25335 ↗
22. Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats10.2147/IJN.S117425 ↗
23. A dual-functional chitosan derivative platform for fungal keratitis10.1016/j.carbpol.2021.118762 ↗
24. Celastrol-based nanomedicine promotes corneal allograft survival10.1186/s12951-021-01079-w ↗
25. The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles
26. Modulation of fibroblasts in conjunctival wound healing10.1016/j.ophtha.2017.08.028 ↗
27. Autophagy in kidney homeostasis and disease10.1038/s41581-020-0309-2 ↗
28. Autophagy in the pathogenesis of disease10.1016/j.cell.2007.12.018 ↗
29. c-FLIP regulates autophagy by interacting with Beclin-1 and influencing its stability10.1038/s41419-021-03957-5 ↗
30. Simultaneous induction and blockade of autophagy by a single agent10.1038/s41419-018-0383-6 ↗
31. Fibrometabolism-An emerging therapeutic frontier in pulmonary fibrosis10.1126/scisignal.aay1027 ↗
32. Autophagy regulates TGF-β expression and suppresses kidney fibrosis induced by unilateral ureteral obstruction10.1681/ASN.2013101068 ↗
33. TOR signaling in growth and metabolism10.1016/j.cell.2006.01.016 ↗
34. Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo10.1016/j.biopha.2021.111318 ↗
35. 2D MOF periodontitis photodynamic ion therapy10.1021/jacs.1c07875 ↗
36. Biocompatible and biodegradable 3D double-network fibrous scaffold for excellent cell growth10.1166/jbn.2019.2846 ↗
37. Atomic-Sn-enabled high utilization, large-capacity, and long-life Na anode10.1126/sciadv.abm7489 ↗
38. Emerging functional porous polymeric and carbonaceous materials for environmental treatment and energy storage10.1002/adfm.201907006 ↗
39. New anode material produces better lithium- and sodium-ion batteries
40. Porous polymers as multifunctional material platforms toward task-specific applications